PRIME DIABETES PHYSICAL
Mdb37-013	GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study
	Quote:	Adipose tissue differences (-4.8 internal torso, -3.2 subcutaneous) were nonsignificant. Conclusions. In this first population-based comparison of whole-body MRI before and after GLP-1 RA initiation with matched unexposed controls, initiators lost roughly 60 more muscle. Skeletal muscle loss is a measurable component of GLP-1 RA weight loss in routine care.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.09.15.26363157v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.09.15.26363157v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Era Stambollxhiu Jannik Luebberstedt Miriam Kumpf Stefan N. Willich Thomas Keil Tobias Pischon Thoralf Niendorf Annette Peters Sebastian Ziegelmayer Marcus R. Makowski Keno K. Bressem Lisa C. Adams,
PRIME DIABETES NUTRITION
Mnu37-013	Short-term postprandial glucose monitoring reveals stable traits from noisy free-living meals
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.09.14.26362991v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.09.14.26362991v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Marouane Toumi Marcel Salath,
DIABETES HEART
Mrh37-013	Treatment of ANCA-Associated Vasculitis With Avacopan: Results of the ADVOCATE Trial After Readjudication of the Primary Endpoint
	Quote:	Conclusions Treatment of GPA/MPA with avacopan in combination with rituximab or cyclophosphamide, when compared with a prednisone taper, resulted in similarly high rates of remission and sustained remission, but reductions in glucocorticoid exposure and toxicity.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.09.16.26363171v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.09.16.26363171v1 .full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	David Jayne Peter A. Merkel Xinyu Tang Zachary S. Wallace Casey P. Norris Nikieia Hayden Sumita Bhatta Renato D. Lopes Amy Stallings,
AI-CHAT PRIME DIABETES DRUGS OBESITY
Sd372-018	AI Uncovers Hidden Ozempic Side Effects Across 400,000 Reddit Posts
	Quote:	Artificial intelligence is giving researchers a new way to listen to what patients are saying about popular GLP-1 drugs. After analyzing more than 400,000 Reddit posts, a University of Pennsylvania team identified several symptoms reported by people using semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound) that may not be fully represented in clinical trials or official regulatory information.
	Article:	https://www.sciencedaily.com//releases/2026/09/260912222856.htm
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
DIABETES OBESITY
Sd372-046	Ozempic and Wegovy May Raise Hair Loss Risk in Some Men
	Article:	https://www.sciencedaily.com//releases/2026/09/260911214241.htm
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho

Javilk's Research Links Newsletter for Week 37
Updated 09/19/2026-02:54:36 AM
What interests you? What have you found? Tell me!
Drop me a note at Javilk.com to subscribe or submit something.

Mdb37-013

GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study

Mnu37-013

Short-term postprandial glucose monitoring reveals stable traits from noisy free-living meals

Mrh37-013

Treatment of ANCA-Associated Vasculitis With Avacopan: Results of the ADVOCATE Trial After Readjudication of the Primary Endpoint

Sd372-018

AI Uncovers Hidden Ozempic Side Effects Across 400,000 Reddit Posts

Sd372-046

Ozempic and Wegovy May Raise Hair Loss Risk in Some Men